Results 241 to 250 of about 88,842 (261)
Some of the next articles are maybe not open access.
Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease
Annals of Neurology, 2003Anthony H V, Schapira, C Warren, Olanow
openaire +2 more sources
The inhibition of dopamine-β-oxidase by chelating agents
Biochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects, 1964openaire +1 more source
Dopamine-β-hydroxylase in cerebrospinal fluid and plasma: Effects of α-adrenergic agents
Brain Research, 1980Leslie F Major, P Lerner
exaly

